Guest guest Posted August 1, 2010 Report Posted August 1, 2010 Hi Lois I cannot find this trial listed in http://www.clinicaltrials.gov/ct2/results?term=hepatitis+c There are 978 trials, so I refined the search. Here is step by step what I did. - http://www.clinicaltrials.gov/ct2/results/browse?term=hepatitis+c - select Sponcer/Alphabetic - http://www.clinicaltrials.gov/ct2/results/browse?term=hepatitis+c & brwse=spns_alpha - select P - http://www.clinicaltrials.gov/ct2/results/browse?term=hepatitis+c & brwse=spns_alpha_p - select Pharmasset And I end up here with 4 studies: http://www.clinicaltrials.gov/ct2/results?term=hepatitis+c & spons=%22Pharmasset%22 & spons_ex=Y I dont see this trial listed - PSI-352938 ("PSI-938") Perhaps it is just too soon, and the site must be updated. In the article is this phone number - Office: +1 [609] 613-4181 Try calling it and see what you can find out. I will keep looking on my end too. love don in ks From: Lois <lab_0422@...>Subject: [ ] RE: Has anyone heard of this clinical trial Date: Sunday, August 1, 2010, 6:32 PM Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938 in Patients with Chronic Hepatitis C-- PSI-938 single ascending dose study in healthy volunteers supports progression to 7 day monotherapy study in HCV infected patients -- PSI-938 was generally safe and well tolerated with no dose-limiting toxicity -- Further results from single ascending and multiple ascending dose trials are expected in the third quarter 2010 I found this on the business page. Below is the link to the page on the article.I was just wondering if this a drug that we would be able to take without peg/rib combo. I am going to ask my doctor about it.here is linkhttp://finance./news/Pharmasset-Initiates-Phase-1b-prnews-539778225.html?x=0 & .v=1ThanksLois------------------------------------ Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.